The Motor Neurological Soft Signs (MNSS) in Persons With Schizophrenia

The Motor Neurological Soft Signs (MNSS) in Persons With Schizophrenia

Sponsors

Lead Sponsor: Faculdade de Motricidade Humana

Source Faculdade de Motricidade Humana
Brief Summary

The aim is to contribute to the knowledge of the relationship between Motor Neurological Soft Signs (MNSS) and schizophrenia, as well as to point out the implications and recommendations for clinical and rehabilitative practices, in order to contribute to the identification of these signs as potential facilitators of prevention and a better follow-up in the psychosocial rehabilitation processes of the person with schizophrenia.

Detailed Description

The aim is to contribute to the knowledge of the relationship between Motor Neurological Soft Signs (MNSS) and schizophrenia, as well as to point out the implications and recommendations for clinical and rehabilitative practices, in order to contribute to the identification of these signs as potential facilitators of prevention and a better follow-up in the psychosocial rehabilitation processes of the person with schizophrenia. It is therefore important to answer the following starting questions: - How can MNSS be assessed and analysed in the Portuguese population with schizophrenia? - How does the manifestation of MNSS differ between people with and without schizophrenia? - Do the MNSS of people with schizophrenia vary according to their functionality level including the following areas of activity (Cognition, Mobility, Self-Care, Interpersonal Relations, Daily Activities and Participation) and their motor experiences? - How can the information obtained by applying a validated assessment tool for this purpose be made operational as a procedure for psychomotor assessment and intervention with this population? The following objectives have been defined to answer these questions, which guide the work: 1. Translate, adapt and validate the BMS instrument (Jahn et al., 2006) for the Portuguese population with schizophrenia; 2. Explore the relationship of MNSS with demographic variables (e.g.: age, gender, education), clinical-therapeutic variables (e.g.: age of diagnosis, number of hospitalizations, medication, type of support) and psychosocial variables (e.g.: functionality, satisfaction and well-being, motor experiences); 3. Test a multifactorial model of the relationships between MNSS, demographic variables, functional clinical-therapeutic and psychosocial; 4. Compare MNSS in people with schizophrenia and people from a healthy control group.

Overall Status Completed
Start Date 2017-01-01
Completion Date 2020-06-01
Primary Completion Date 2019-12-01
Phase N/A
Study Type Interventional
Primary Outcome
Measure Time Frame
Assessment of persons with schizophrenia with Brief Motor Scale - Portuguese version (BMS_pt) instrument 6 weeks
Enrollment 103
Condition
Intervention

Intervention Type: Diagnostic Test

Intervention Name: Brief Motor Scale_portuguese version (BMS_pt)

Description: translate, adapt and validate Brief Motor Scale for portuguese population with schizophrenia

Arm Group Label: Motor Neurological Soft Signs

Eligibility

Criteria:

Inclusion Criteria: - Have a schizophrenia diagnoses Exclusion Criteria: - Have a motor disability - Drugs consumer

Gender:

All

Minimum Age:

18 Years

Maximum Age:

N/A

Healthy Volunteers:

No

Overall Official
Last Name Role Affiliation
Susana Guimarães, MD Principal Investigator Faculdade Motricidade Humana
Location
Facility: Susana Guimarães
Location Countries

Portugal

Verification Date

2020-07-01

Responsible Party

Type: Principal Investigator

Investigator Affiliation: Faculdade de Motricidade Humana

Investigator Full Name: Susana Guimarães, MD

Investigator Title: Principal Investigator

Has Expanded Access No
Condition Browse
Number Of Arms 1
Arm Group

Label: Motor Neurological Soft Signs

Type: Other

Description: motor test and an interview for the participants

Acronym MNSS
Patient Data No
Study Design Info

Allocation: N/A

Intervention Model: Single Group Assignment

Primary Purpose: Supportive Care

Masking: None (Open Label)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Research News